Xenia Sango
Company: VivaZome Therapeutics
Job title: Chief Executive Officer & Managing Director
Bio:
Xenia Sango
Chief Executive Officer and Managing Director
Xenia Sango is a highly experienced healthcare executive with over 35 years in operational leadership, international business, and senior clinical and regulatory roles. Prior to VivaZome, Xenia’s positions at CSL Limited included Senior Director of Influenza Commercial Operations; Director of International Registrations, and Head of Regulatory Affairs. Xenia’s experience included setting up CSL’s global regulatory function, and launching CSL’s Fluvax in US and Europe, including establishing subsidiaries in USA and Germany. In Japan, Xenia set up commercial and manufacturing operations for CSL. As Business Development Manager Research at Epworth HealthCare, Xenia expanded the research business, managed the Clinical Research Unit and set up Phase 1b capability. Xenia has been part of VivaZome since its inception, most recently in the COO role prior to her appointment as CEO and MD
Seminars:
Chair’s Opening Remarks 8:50 am
day: Conference Day Two
Roundtable Discussion: into Market Conditions for Exosome/EV Therapy Development 1:00 pm
Understanding how market conditions can influence investor interest and funding availability for exosome and EV therapy development Demonstrating clinical promise and addressing regulatory hurdles to mitigate investor concerns and maintain confidence in exosome and EV-based therapies Exploring the potential for new innovations in exosome and EV development to attract investment in exosome therapy developmentRead more
day: Conference Day Two